<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">V.F.Snegirev Archives of Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">V.F.Snegirev Archives of Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Архив акушерства и гинекологии им. В.Ф. Снегирева</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-8726</issn><issn publication-format="electronic">2687-1386</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">111031</article-id><article-id pub-id-type="doi">10.17816/2313-8726-2022-9-3-163-171</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="zh"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Newborns in the early neonatal period in a group of mothers at high obstetric and perinatal risk</article-title><trans-title-group xml:lang="ru"><trans-title>Новорождённые в раннем неонатальном периоде в группе матерей высокого акушерского и перинатального риска</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7882-8922</contrib-id><name-alternatives><name xml:lang="en"><surname>Samchuk</surname><given-names>Petr M.</given-names></name><name xml:lang="ru"><surname>Самчук</surname><given-names>Петр Михайлович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>samchuk_p_m@staff.sechenov.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1773-7474</contrib-id><name-alternatives><name xml:lang="en"><surname>Tsaroeva</surname><given-names>Inna K.</given-names></name><name xml:lang="ru"><surname>Цароева</surname><given-names>Инна Хасановна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>postgraduate student</p></bio><bio xml:lang="ru"><p>аспирант</p></bio><email>tsaroevainna@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3338-1113</contrib-id><name-alternatives><name xml:lang="en"><surname>Ishchenko</surname><given-names>Anatoliy I.</given-names></name><name xml:lang="ru"><surname>Ищенко</surname><given-names>Анатолий Иванович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>7205502@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3711-2423</contrib-id><name-alternatives><name xml:lang="en"><surname>Azoeva</surname><given-names>Evelina L.</given-names></name><name xml:lang="ru"><surname>Азоева</surname><given-names>Эвелина Лазаревна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>postgraduate student, gynecologist</p></bio><bio xml:lang="ru"><p>аспирант, врач акушер-гинеколог</p></bio><email>ewelina.azoeva@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Moscow State Clinical Hospital named after V.V. Veresaev</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница им. В.В. Вересаева</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-09-23" publication-format="electronic"><day>23</day><month>09</month><year>2022</year></pub-date><volume>9</volume><issue>3</issue><issue-title xml:lang="ru"/><fpage>163</fpage><lpage>171</lpage><history><date date-type="received" iso-8601-date="2022-09-23"><day>23</day><month>09</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-09-23"><day>23</day><month>09</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Samchuk P.M., Tsaroeva I.K., Ishchenko A.I., Azoeva E.L.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Самчук П.М., Цароева И.Х., Ищенко А.И., Азоева Э.Л.</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2022,</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Samchuk P.M., Tsaroeva I.K., Ishchenko A.I., Azoeva E.L.</copyright-holder><copyright-holder xml:lang="ru">Самчук П.М., Цароева И.Х., Ищенко А.И., Азоева Э.Л.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2024-09-23"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://archivog.com/2313-8726/article/view/111031">https://archivog.com/2313-8726/article/view/111031</self-uri><abstract xml:lang="en"><p><bold><italic>AIM:</italic></bold> We aimed at assessing the status of newborns in the early neonatal period in a group of mothers at high prenatal risk for preeclampsia (PE), fetal growth restriction (FGR), preterm birth (PTB), and fetal chromosomal abnormalities (FCA).</p> <p><bold><italic>MATERIALS AND METHODS:</italic></bold> We prospectively analyzed the status of 435 singletons. Mothers in the first-trimester underwent prenatal screening with risk assessment. Group 1 (study group, <italic>n</italic>=231) included high-risk subgroups for FCA (subgroup 1A, <italic>n</italic>=67), maternal PE (subgroup 1B, <italic>n</italic>=66), FGR (subgroup 1C, <italic>n</italic>=46), and PTB (subgroup 1D, <italic>n</italic>=52). We excluded risk combinations. Group 2 (controls) included 204 children of low-risk women.</p> <p><bold><italic>RESULTS:</italic></bold> Group 1 had a higher incidence of mild-to-moderate asphyxia compared with group 2 (<italic>p</italic> &lt;0.05) and was more frequent in 1B, 1C, and 1D subgroups. Moreover, the frequency of severe asphyxia was similar between the groups (<italic>p</italic> &gt;0.05). Intrauterine growth restriction (IUGR) and developmental delay were more frequent in group 1 than in group 2 (<italic>p</italic> &lt;0.05). Moreover, group 1 children required monitoring and treatment more frequently that in group 2 (<italic>p</italic> &lt;0.05). The frequency of infectious complications in group 1 and 1A, 1B, and 1C subgroups was equally higher than that of group 2 (<italic>p</italic> &lt;0.05), while respiratory distress syndrome predominated in group 1 (subgroup 1D) and was not observed in group 2. The discharge rate was 95.7% in group 1 and 84.0% in group 2 (<italic>p</italic> &lt;0.05). On days 3 to 5, 16% and 3.4% of children in groups 1 and 2, respectively, were transferred to the second stage of aftercare (<italic>p</italic> &lt;0.05).</p> <p><bold><italic>CONCLUSIONS:</italic></bold> In the early neonatal period, children born to high-risk mothers, as opposed to those born to low-risk mothers, were significantly more likely to have asphyxia, IUGR, infectious complications, and indications for continued treatment in the second stage of nursing.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель исследования </bold>― оценить состояние новорождённых в раннем неонатальном периоде в группе матерей высокого пренатального риска по развитию преэклампсии (ПЭ), задержки роста плода (ЗРП), преждевременных родов (ПР) и хромосомных аномалий у плода (ХА).</p> <p><bold>Материалы и методы.</bold> Проведён проспективный анализ состояния новорождённых от 435 одноплодных родов. Матерям в I триместре выполнен пренатальный скрининг с оценкой риска. В 1-ю, основную группу (<italic>n</italic>=231) включили подгруппы с высоким риском по развитию ХА у плода ― подгруппа 1А (<italic>n</italic>=67), ПЭ у матерей ― подгруппа 1В (<italic>n</italic>=66), ЗРП ― подгруппа 1С (<italic>n</italic>=46), ПР ― подгруппа 1D (<italic>n</italic>=52). Исключены сочетания рисков. Вторая, контрольная группа включала 204 ребёнка от женщин с низким риском.</p> <p><bold>Результаты.</bold> В 1-й группе отмечена более высокая частота рождения детей в состоянии асфиксии лёгкой и средней степени, чем во 2-й группе (<italic>р</italic> &lt;0,05), и чаще в подгруппах 1В, 1С и 1D. Частота тяжёлой асфиксии не имела отличий между группами (<italic>р</italic> &gt;0,05). Задержка внутриутробного роста и развития (ЗВУР) в 1-й группе встречалась чаще, чем во 2-й (<italic>р</italic> &lt;0,05). Наблюдение и лечение потребовалось детям 1-й группы чаще, чем детям 2-й группы (<italic>р</italic> &lt;0,05). Частота инфекционных осложнений у детей в 1-й группе и в подгруппах 1А, 1В и 1С оказалась выше, чем во 2-й группе (<italic>р</italic> &lt;0,05). Респираторный дистресс-синдром преобладал в 1-й группе в подгруппе 1D, во 2-й группе он не отмечен. Выписаны 84,0% детей 1-й группы и 95,7% детей 2-й группы (<italic>р</italic> &lt;0,05). На 3–5-е сутки 16% детей 1-й группы переведены на 2-й этап долечивания, во 2-й группе ― 3,4% (<italic>р</italic> &lt;0,05).</p> <p><bold>Заключение.</bold> У детей, рождённых от матерей с высоким риском, в отличие от рождённых от матерей с низким риском, в раннем неонатальном периоде достоверно чаще отмечены асфиксия, ЗВУР, инфекционные осложнения и показания к продолжению лечения на втором этапе выхаживания.</p></trans-abstract><trans-abstract xml:lang="zh"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>asphyxia</kwd><kwd>intrauterine growth</kwd><kwd>intrauterine growth restriction</kwd><kwd>newborns</kwd><kwd>prenatal screening</kwd><kwd>risk level</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>асфиксия</kwd><kwd>внутриутробное развитие</kwd><kwd>задержка внутриутробного роста</kwd><kwd>новорождённые</kwd><kwd>пренатальный скрининг</kwd><kwd>степень риска</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Zamanskaya TA, Evseeva ZP, Evseev AV. Biochemical screening in the first trimester in predicting pregnancy complications. Russian Bulletin of Obstetrician-Gynecologist. 2009;3:14–18. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Заманская Т.А., Евсеева З.П., Евсеев А.В. Биохимический скрининг в I триместре при прогнозировании осложнений беременности // Российский вестник акушера-гинеколога. 2009. № 3. С. 14–18.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Cuckle H, Platt LD, Thornburg LL, et al. Nuchal Translucency Quality Review (NTQR) program: first one and half million results. Ultrasound Obstet Gynecol. 2015;45(2):199–204. doi: 10.1002/uog.13390</mixed-citation><mixed-citation xml:lang="ru">Cuckle H., Platt L.D., Thornburg L.L., et al. Nuchal Translucency Quality Review (NTQR) program: first one and half million results // Ultrasound Obstet Gynecol. 2015. Vol. 45, N 2. P. 199–204. doi: 10.1002/uog.13390</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Breathnach FM, Malone FD, Lambert-Messerlian G. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol. 2007;110(3):651–657. doi: 10.1097/01.AOG.0000278570.76392.a6</mixed-citation><mixed-citation xml:lang="ru">Breathnach F.M., Malone F.D., Lambert-Messerlian G. First- and second-trimester screening: detection of aneuploidies other than Down syndrome // Obstet Gynecol. 2007. Vol. 110, N 3. P. 651–657. doi: 10.1097/01.AOG.0000278570.76392.a6</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Coco C, Jeanty P. Isolated fetal pyelectasis and chromosomal abnormalities. Am J Obstet Gynecol. 2005;193(3 Pt 1):732–738. doi: 10.1016/j.ajog.2005.02.074</mixed-citation><mixed-citation xml:lang="ru">Coco C., Jeanty Ph. Isolated fetal pyelectasis and chromosomal abnormalities // Am J Obstet Gynecol. 2005. Vol. 193, No. 3 Pt 1. P. 732–738. doi: 10.1016/j.ajog.2005.02.074</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Smith-Bindman R, Chu P, Goldberg JD. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome. Prenat Diagn. 2007;27(6):535–544. doi: 10.1002/pd.172527:535</mixed-citation><mixed-citation xml:lang="ru">Smith-Bindman R., Chu P., Goldberg J.D. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome // Prenat Diagn. 2007. Vol. 27, N 6. P. 535–544. doi: 10.1002/pd.1725</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Order of the Ministry of Health of the Russian Federation No. 1130n dated October 20, 2020 «Ob utverzhdenii Poryadka oka zaniya meditsinskoi pomoshchi po profilyu akusherstvo i gine kologiya». Available from: 1130n.pdf. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Приказ Министерства здравоохранения РФ от 20 октября 2020 г. № 1130н «Об утверждении Порядка оказания медицинской помощи по профилю «акушерство и гинекология». Режим доступа: 1130n.pdf. Дата обращения: 04.07.2022.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Palomaki GE, Lambert-Messerlian GM, Canick JA. A summary analysis of Down syndrome markers in the late first trimester. Adv Clin Chem. 2007;43:177–210.</mixed-citation><mixed-citation xml:lang="ru">Palomaki G.E., Lambert-Messerlian G.M., Canick J.A. A summary analysis of Down syndrome markers in the late first trimester // Adv Clin Chem. 2007. Vol. 43. P. 177–210.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178(6):701–711. doi: 10.1503/cmaj.070430</mixed-citation><mixed-citation xml:lang="ru">Cnossen J.S., Morris R.K., ter Riet G., et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis // CMAJ. 2008. Vol. 178, N 6. P. 701–711. doi: 10.1503/cmaj.070430</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Palomaki GE, Eklund EE, Neveux LM, Lambert Messerlian GM. Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures. Prenat Diagn. 2015;35(8):789–796. doi: 10.1002/pd.4609</mixed-citation><mixed-citation xml:lang="ru">Palomaki G.E., Eklund E.E., Neveux L.M., Lambert Messerlian G.M. Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures // Prenat Diagn. 2015. Vol. 35, N 8. P. 789–796. doi: 10.1002/pd.4609</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Than NG, Romero R, Hillermann R, et al. Prediction of pre eclam psia ― a workshop report. Placenta. 2008;29 Suppl. A:S83–85. doi: 10.1016/j.placenta.2007.10.008</mixed-citation><mixed-citation xml:lang="ru">Than N.G., Romero R., Hillermann R., et al. Prediction of preeclampsia ― a workshop report // Placenta. 2008. Vol. 29, Suppl. A. P. S83–S85. doi: 10.1016/j.placenta.2007.10.008</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Grill S, Rusterholz C, Zanetti-Dällenbach R, et al. Potential markers of preeclampsia ― a review. Reprod Biol Endocrinol. 2009;7(70):1–14. doi: 10.1186/1477-7827-7-70</mixed-citation><mixed-citation xml:lang="ru">Grill S., Rusterholz C., Zanetti-Dällenbach R., et al. Potential markers of preeclampsia ― a review // Reprod Biol Endocrinol. 2009. Vol. 7, N 70. P. 1–14. doi: 10.1186/1477-7827-7-70</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Dagklis T, Plasencia W, Maiz N. Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol. 2008;31(2):132–135. doi: 10.1002/uog.5224</mixed-citation><mixed-citation xml:lang="ru">Dagklis T., Plasencia W., Maiz N., Duarte l., Nicolaides K.H. Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks // Ultrasound Obstet Gynecol. 2008. Vol. 31, N 2. P. 132–135. doi: 10.1002/uog.5224</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Hedley PL, Placing S, Wøjdemann K, Carlsen AL, Shalmi AC. Free leptin index and PAPP-A: a first trimester maternal serum screening test for pre-eclampsia. Prenat Diagn. 2010;30(2):103–109. doi: 10.1002/pd.2337</mixed-citation><mixed-citation xml:lang="ru">Hedley P.L., Placing S., Wøjdemann K., Carlsen A.L., Shalmi A.C. Free leptin index and PAPP-A: a first trimester maternal serum screening test for pre-eclampsia // Prenat Diagn. 2010. Vol. 30, N 2. P. 103–109. doi: 10.1002/pd.2337</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Lain SJ, Algert CS, Tasevski V, Morris JM. Record linkage to obtain birth outcomes for the evaluation of screening biomarkers in pregnancy: a feasibility study. BMC Med Res Methodol. 2009;9:48. doi: 10.1186/1471-2288-9-48</mixed-citation><mixed-citation xml:lang="ru">Lain S.J., Algert C.S., Tasevski V., Morris J.M., Roberts C.L. Record linkage to obtain birth outcomes for the evaluation of screening biomarkers in pregnancy: a feasibility study // BMC Med Res Methodol. 2009. Vol. 9. P. 48. doi: 10.1186/1471-2288-9-48</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Volodin NN, ed. Neonatologiya. Natsional’noe rukovodstvo. Moscow: GEOTAR-Media; 2009. 848 p. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Неонатология. Национальное руководство / под ред. Н.Н. Володина. Москва : ГЭОТАР-Медиа, 2009. 848 с.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Belousova TV, Andrushina IV. Intrauterine growth retardation and its impact on children’s health in after-life. The possibility of nutrition support. Current Pediatrics. 2015;14(1):23–30. (In Russ). doi: 10.15690/vsp.v14i1.1259</mixed-citation><mixed-citation xml:lang="ru">Белоусова Т.В., Андрюшина И.В. Задержка внутриутробного развития и её влияние на состояние здоровья детей в последую щие периоды жизни. Возможности нутритивной коррекции // Вопросы современной педиатрии. 2015. Т. 14, № 1. С. 23–30. doi: 10.15690/vsp.v14i1.1259</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">American College of Obstetricians and Gynecologists. ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol. 2013;121(5):1122–1133. doi: 10.1097/01.AOG.0000429658.85846.f9</mixed-citation><mixed-citation xml:lang="ru">American College of Obstetricians and Gynecologists. ACOG Practice bulletin No. 134: fetal growth restriction // Obstet. Gynecol. 2013. Vol. 121, N 5. P. 1122–1133. doi: 10.1097/01.AOG.0000429658.85846.f9</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Baer RJ, Rogers EE, Partridge JC, et al. Population-based risks of mortality and preterm morbidity by gestational age and birth weight. J Perinatol. 2016;36(11):1008–1013. doi: 10.1038/jp.2016.118</mixed-citation><mixed-citation xml:lang="ru">Baer R.J., Rogers E.E., Partridge J.C., et al. Population-based risks of mortality and preterm morbidity by gestational age and birth weight // J Perinatol. 2016. Vol. 36, N 11. P. 1008–1013. doi: 10.1038/jp.2016.118</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Iliodromiti S, Mackay DF, Smith GC, et al. Customised and noncustomised birth weight centiles and prediction of stillbirth and infant mortality and morbidity: a cohort study of 979,912 term singleton pregnancies in Scotland. PLoS Med. 2017;14(1):e1002228. doi: 10.1371/journal.pmed.1002228</mixed-citation><mixed-citation xml:lang="ru">Iliodromiti S., Mackay D.F., Smith G.C., et al. Customised and noncustomised birth weight centiles and prediction of stillbirth and infant mortality and morbidity: a cohort study of 979,912 term singleton pregnancies in Scotland // PLoS Med. 2017. Vol. 14, N 1. P. e1002228. doi: 10.1371/journal.pmed.1002228</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Beune IM, Bloomfield FH, Ganzevoort W, et al. Consensus based definition of growth restriction in the newborn. J Pediatr. 2018;196:71–76.e1. doi: 10.1016/j.jpeds.2017.12.059</mixed-citation><mixed-citation xml:lang="ru">Beune I.M., Bloomfield F.H., Ganzevoort W., et al. Consensus based definition of growth restriction in the newborn // J Pediatr. 2018. Vol. 196. P. 71–76.e1. doi: 10.1016/j.jpeds.2017.12.059</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr. 2016;86(6):361–397. doi: 10.1159/000452150</mixed-citation><mixed-citation xml:lang="ru">Grimberg A., DiVall S.A., Polychronakos C., et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency // Horm Res Paediatr. 2016. Vol. 86, N 6. P. 361–397. doi: 10.1159/000452150</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Beukers F, Rotteveel J, van Weissenbruch MM, et al. Growth throughout childhood of children born growth restricted. Arch Dis Child. 2017;102(8):735–741. doi: 10.1136/archdischild-2016-312003</mixed-citation><mixed-citation xml:lang="ru">Beukers F., Rotteveel J., van Weissenbruch M.M., et al. Growth throughout childhood of children born growth restricted // Arch Dis Child. 2017. Vol. 102, N 8. P. 735–741. doi: 10.1136/archdischild-2016-312003</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Sharma D, Shastri S, Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin Med Insights Pediatr. 2016;10:67–83. doi: 10.4137/CMPed.S40070</mixed-citation><mixed-citation xml:lang="ru">Sharma D, Shastri S, Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects // Clin Med Insights Pediatr. 2016. Vol. 10. P. 67–83. doi: 10.4137/CMPed.S40070</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Order of the Moscow Department of Health of 14.06.2013 No. 600 (ed. of 12.03.2015) «O sovershenstvovanii organizatsii prenatal’noi (dorodovoi) diagnostiki narushenii razvitiya ploda/rebenka». Moscow; 2013. Available from: http://pravo-med.ru/legislation/rz/5298/?ysclid=l5772bj5bg449907749. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Приказ Департамента здравоохранения г. Москвы от 14.06.2013 № 600 (ред. от 12.03.2015) «О совершенствовании организации пренатальной (дородовой) диагностики нарушений развития плода/ребёнка». Москва, 2013. Режим доступа: http://pravo-med.ru/legislation/rz/5298/?ysclid=l5772bj5bg449907749. Дата обращения: 04.07.2022.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Protopopova NV, Samchuk PM, Kravchuk NV. Clinical protocols [Klinicheskie protokoly]. Irkutsk, 2006. Available from: https://studfile.net/preview/6233996/. (in Russ).</mixed-citation><mixed-citation xml:lang="ru">Протопопова Н.В., Самчук П.М., Кравчук Н.В. Клинические протоколы. Иркутск, 2006. Режим доступа: https://studfile.net/preview/6233996/. Дата обращения: 04.07.2022.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Health Service Executive. Сlinical Practice Guideline. Fetal growth restriction — recognition, diagnosis and ma nagement. Available from: https://www.hse.ie/eng/services/pub li cations/clinical-strategy-and-programmes/fetal-growth-restriction.pdf</mixed-citation><mixed-citation xml:lang="ru">Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Health Service Executive. Сlinical Practice Guideline. Fetal growth restriction — recognition, diagnosis and management. Режим доступа: https://www.hse.ie/eng/services/publications/clinical-strategy-and-programmes/fetal-growth-restriction.pdf. Дата обращения: 05.07.2022.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Blue NR, Beddow ME, Savabi M, et al. A comparison of methods for the diagnosis of fetal growth restriction between the Royal College of Obstetricians and Gynaecologists and the American College of Obstetricians and Gynecologists. Obstet Gynecol. 2018;131(5):835–841. doi: 10.1097/AOG.0000000000002564</mixed-citation><mixed-citation xml:lang="ru">Blue N.R., Beddow M.E., Savabi M., et al. A comparison of methods for the diagnosis of fetal growth restriction between the Royal College of Obstetricians and Gynaecologists and the American College of Obstetricians and Gynecologists // Obstet Gynecol. 2018. Vol. 131, N 5. P. 835–841. doi: 10.1097/AOG.0000000000002564</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Kanasaki K, Kalluri R. The biology of preeclampsia. Kidney Int. 2009;76(8):831–837 doi: 10.1038/ki.2009.284</mixed-citation><mixed-citation xml:lang="ru">Kanasaki K., Kalluri R. The biology of preeclampsia // Kidney Int. 2009. Vol. 76, N 8. P. 831–837. doi: 10.1038/ki.2009.284</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Orlov VI, Krymshokalova ZS, Maklyuk AM, et al. Rannie markery gestoza beremennykh i zaderzhki rosta ploda. Vestnik Rossiiskogo universiteta druzhby narodov. 2009;(7):21–25. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Орлов В.И., Крымшокалова З.С., Маклюк А.М., и др. Ранние маркеры гестоза беременных и задержки роста плода // Вестник РУДН. 2009. № 7. С. 21–25.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
